Exec-Edge – Page 2 – ExecEdge

Glucotrack to File for FDA Exemption Based on 2025 Milestones

Glucotrack to File for FDA Exemption Based on 2025 Milestones

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said it will request an Investigational Device Exemption (IDE) from the FDA for its continuous blood glucose monitoring technology. This submission follows the completion of clinical trials in Brazil and Australia, and is...

Input your search keywords and press Enter.